Thursday, 15 October 2026European Markets

GJENSIDIGE FORSIKR And PEUGEOT INVEST Have A High Dividend Yield And Return On Equity In The Financial Services Sector.

Loading stream...

(vianews) - gjensidige forsikr (gjf.ol) is among this list of stock assets with the highest dividend rate and return on equity on the financial services sector.

financial asset price forward dividend yield return on equity
gjensidige forsikr (gjf.ol) kr164.30 5.02% 23.73%
peugeot invest (peug.pa) €102.00 2.77% 4.8%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. gjensidige forsikr (gjf.ol)

5.02% forward dividend yield and 23.73% return on equity

gjensidige forsikring asa provides general insurance and pension products in norway, sweden, denmark, latvia, lithuania, and estonia. the company operates through six segments: general insurance private, general insurance commercial, general insurance denmark, general insurance sweden, general insurance baltics, and pension. it offers motor, accident and health, travel, leisure craft, valuables, liability, commercial, marine/transport, agriculture, natural perils, life, and pet insurance products. the company also provides defined contribution occupational pension schemes for businesses, which include disability pension, spouse/cohabitant pension, and child's pension products. it distributes its products through various distribution channels comprising office channel, call center, internet, partners, and brokers to private and commercial customers. the company was founded in 1816 and is headquartered in oslo, norway.

earnings per share

as for profitability, gjensidige forsikr has a trailing twelve months eps of kr10.85.

pe ratio

gjensidige forsikr has a trailing twelve months price to earnings ratio of 15.14. meaning, the purchaser of the share is investing kr15.14 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.73%.

growth estimates quarters

the company's growth estimates for the current quarter is 43.4% and a drop 8.7% for the next.

sales growth

gjensidige forsikr's sales growth is negative 28.9% for the ongoing quarter and negative 66.4% for the next.

moving average

gjensidige forsikr's worth is above its 50-day moving average of kr159.89 and below its 200-day moving average of kr176.58.

earnings before interest, taxes, depreciation, and amortization

gjensidige forsikr's ebitda is 2.22.

more news about gjensidige forsikr.

2. peugeot invest (peug.pa)

2.77% forward dividend yield and 4.8% return on equity

peugeot invest société anonyme operates as an investment company. the firm invests in private equity and real estate funds. the firm also invests in governance, social, and environmental protection. the company was formerly known as ffp société anonyme and changed its name to peugeot invest société anonyme. peugeot invest société anonyme was incorporated in 1929 and is headquartered in paris, france.

earnings per share

as for profitability, peugeot invest has a trailing twelve months eps of €9.52.

pe ratio

peugeot invest has a trailing twelve months price to earnings ratio of 10.71. meaning, the purchaser of the share is investing €10.71 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.8%.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on may 19, 2023, the estimated forward annual dividend rate is 2.85 and the estimated forward annual dividend yield is 2.77%.

volume

today's last reported volume for peugeot invest is 338 which is 92.99% below its average volume of 4824.

more news about peugeot invest.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com